SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-16-003540
Filing Date
2016-02-25
Accepted
2016-02-25 16:30:50
Documents
3
Period of Report
2016-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aegr-20160225x8k.htm 8-K 43340
2 EX-99.1 aegr-20160225ex991325c2d.htm EX-99.1 357025
3 GRAPHIC aegr20160225ex991325c2d001.jpg GRAPHIC 11224
  Complete submission text file 0001558370-16-003540.txt   417242
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 161456358
SIC: 2834 Pharmaceutical Preparations